| NCT Number | NCT06895291 |
| Lead Sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
| Conditions | Lymphoma, Advanced Prostate Cancer, Advanced Breast Cancer, Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, Multiple Myeloma |
| Enrollment | 1,000 participants |
| Start Date | 2023-10-26 |
| Primary Completion | 2028-10 (estimated) |
| Study Completion | 2031-10 (estimated) |
| Updated on ClinicalTrials.gov | 2025-03-30 |